Zoetis (ZTS) Shares are Up 0.24%

Zoetis (ZTS) : During the past 4 weeks, traders have been relatively bearish on Zoetis (ZTS), hence the stock is down -1.88% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -0.29% relative to the S&P 500. The stock has risen by 0.24% in the past week indicating that the buyers are active at lower levels, but the stock is down -3.86% in the past 4 weeks.

The stock has recorded a 20-day Moving Average of 1.16% and the 50-Day Moving Average is 0.27%.The 200 Day SMA reached 8.68% Zoetis Inc. is up 8.99% in the last 3-month period. Year-to-Date the stock performance stands at 6.08%.


Zoetis (ZTS) stock is expected to deviate a maximum of $5.99 from the average target price of $54.67 for the short term period. 6 Street Experts have initiated coverage on the stock with the most promising target being $62 and the most muted being $49.

For the current week, the company shares have a recommendation consensus of Buy. Zoetis (NYSE:ZTS): stock was range-bound between the intraday low of $50.3 and the intraday high of $50.87 after having opened at $50.87 on Fridays session. The stock finally closed in the red at $50.87, a loss of -0.41%. The stock remained in the red for the whole trading day. The total traded volume was 8,679,598 shares. The stock failed to cross $50.87 in Fridays trading. The stocks closing price on Thursday was $50.72.

Zoetis Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company markets products across four regions: the United States, Europe/Africa/Middle East, Canada/Latin America and Asia/Pacific; eight species: the livestock species of cattle, swine, poultry, sheep and fish, and the companion animal species of dogs, cats and horses, and five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceutical products. In addition, its Client Supply Services (CSS) organization provides contract manufacturing services to third parties.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.